Prosecution Insights
Last updated: April 19, 2026

Genesail Biotech (Shanghai) Co. Ltd.

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17274435 A MODIFIED ONCOLYTIC VIRUS, COMPOSITION AND USE THEREOF ROGERS, ERIC JASON 1638 Final Rejection Mar 09, 2021

Managing Genesail Biotech (Shanghai) Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month